Sigma Healthcare confirmed it is in talks to buy UK drugstore chain Boots in a deal worth up to $10 billion. Sycamore Partners, which took control of Boots in 2025, started sale talks with potential strategic buyers before Easter. A sale would scrap plans for a Boots IPO in London.
Tap to vote and see what everyone thinks.